Immatics Payables Turnover from 2010 to 2024

IMTXW Stock  USD 0.41  0.01  2.38%   
Immatics Biotechnologies Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover will likely drop to 15.16 in 2024. Payables Turnover is a liquidity ratio that shows how quickly immatics biotechnologies GmbH pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
15.47912862
Current Value
15.16
Quarterly Volatility
7.87856801
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 13.7 M or Interest Income of 14.5 M, as well as many indicators such as Price To Sales Ratio of 13.5, Dividend Yield of 0.0 or PTB Ratio of 3.58. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Immatics Biotechnologies Correlation against competitors.

Latest Immatics Biotechnologies' Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of immatics biotechnologies GmbH over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Immatics Biotechnologies' Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Slightly volatile
   Payables Turnover   
       Timeline  

Immatics Payables Turnover Regression Statistics

Arithmetic Mean12.90
Geometric Mean11.24
Coefficient Of Variation61.06
Mean Deviation6.40
Median8.09
Standard Deviation7.88
Sample Variance62.07
Range21.0176
R-Value0.66
Mean Square Error37.83
R-Squared0.43
Significance0.01
Slope1.16
Total Sum of Squares869.01

Immatics Payables Turnover History

2024 15.16
2023 15.48
2022 26.53
2021 29.1
2020 26.27
2019 8.24

About Immatics Biotechnologies Financial Statements

Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Payables Turnover 15.48  15.16 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immatics Stock Analysis

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.